These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27661410)

  • 1. The APOE paradox: do attentional control differences in mid-adulthood reflect risk of late-life cognitive decline.
    Lancaster C; Tabet N; Rusted J
    Neurobiol Aging; 2016 Dec; 48():114-121. PubMed ID: 27661410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting attention in the spotlight: The influence of APOE genotype on visual search in mid adulthood.
    Lancaster C; Forster S; Tabet N; Rusted J
    Behav Brain Res; 2017 Sep; 334():97-104. PubMed ID: 28750833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
    Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
    Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of brain activation in people at risk for Alzheimer's disease.
    Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW
    N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and neural signatures of the APOE E4 allele in mid-aged adults.
    Evans S; Dowell NG; Tabet N; Tofts PS; King SL; Rusted JM
    Neurobiol Aging; 2014 Jul; 35(7):1615-23. PubMed ID: 24582638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
    Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired memory-guided attention in asymptomatic APOE4 carriers.
    Zimmermann J; Alain C; Butler C
    Sci Rep; 2019 May; 9(1):8138. PubMed ID: 31148578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses.
    Dilliott AA; Sunderland KM; McLaughlin PM; Roberts AC; Evans EC; Abrahao A; Binns MA; Black SE; Borrie M; Casaubon LK; Dowlatshahi D; Finger E; Fischer CE; Frank A; Freedman M; Grimes D; Hassan A; Jog M; Kumar S; Kwan D; Lang AE; Mandzia J; Marras C; Masellis M; McIntyre AD; Pasternak S; Pollock BG; Rajji TK; Robinson JF; Rogaeva E; Sahlas DJ; Saposnik G; Sato C; Seitz D; Shoesmith C; Steeves T; Strother SC; Swartz RH; Tan B; Tang-Wai D; Tartaglia MC; Troyer AK; Turnbull J; Zinman L; ; Hegele RA
    Neurobiol Aging; 2021 Sep; 105():378.e1-378.e9. PubMed ID: 34039480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and resting-state MRI detects regional brain differences in young and mid-age healthy APOE-e4 carriers compared with non-APOE-e4 carriers.
    Dowell NG; Evans SL; Tofts PS; King SL; Tabet N; Rusted JM
    NMR Biomed; 2016 May; 29(5):614-24. PubMed ID: 26929040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between ApoE gene and psychological consequences post stroke in a Bahraini cohort.
    Donnellan C; Redha N; Al Banna M; Al Sharoqi I; Al-Jishi A; Bakhiet M; Taha S; Abdulla F; Walsh P
    Asian J Psychiatr; 2019 Jan; 39():135-142. PubMed ID: 30622009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
    Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease.
    Morgen K; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
    J Alzheimers Dis; 2013; 37(2):389-401. PubMed ID: 23948881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure.
    Sapkota S; McFall GP; Masellis M; Dixon RA; Black SE
    J Alzheimers Dis; 2022; 85(2):545-560. PubMed ID: 34864669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study.
    Greenwood PM; Lambert C; Sunderland T; Parasuraman R
    Neuropsychology; 2005 Mar; 19(2):199-211. PubMed ID: 15769204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
    Vélez JI; Lopera F; Sepulveda-Falla D; Patel HR; Johar AS; Chuah A; Tobón C; Rivera D; Villegas A; Cai Y; Peng K; Arkell R; Castellanos FX; Andrews SJ; Silva Lara MF; Creagh PK; Easteal S; de Leon J; Wong ML; Licinio J; Mastronardi CA; Arcos-Burgos M
    Mol Psychiatry; 2016 Jul; 21(7):916-24. PubMed ID: 26619808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.